Checkmate Pharmaceuticals

Share on: 
Website: Checkmate Pharmaceuticals

Checkmate Pharmaceuticals is a clinical stage company pursuing ways to specifically activate the innate and adaptive arms of the immune system to recognize and ultimately destroy tumor cells. The company is evaulating CpG oligonucleotides (ODN) to stimulate an anti-tumor T cell response in combination with checkpoint inhibition to overcome a tumor’s ability to suppress the immune response.

Cambridge MA
United States